During the past decade, Hospital Felício Rocho conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 14 clinical trials were completed, i.e. on average, 60.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Felício Rocho" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored and "Hospital Israelita Albert Einstein" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Felício Rocho" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Angiolog Consultoria Ltda" with 1 trials as a collaborator and "Basilea Pharmaceutica" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Felício Rocho" are "COVID-19" (3 trials), "Ulcerative Colitis" (3 trials), "Cardiovascular Diseases" (2 trials), "Coronary Artery Disease" (2 trials) and "Crohn Disease" (2 trials). Many other conditions were trialed in "Hospital Felício Rocho" in a lesser frequency.

Most popular intervention types in "Hospital Felício Rocho" are "Drug" (26 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Etrolizumab" (4 trials), "Empagliflozin" (2 trials), "Mirikizumab" (2 trials) and "Remdesivir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Felício Rocho" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Felício Rocho". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Hospital Felício Rocho, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Felício Rocho, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".